Heart Attack Research Program- Imaging Study
Public ClinicalTrials.gov record NCT02905357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in patients with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every 6 months, for a maximum of 10 years.
Study identification
- NCT ID
- NCT02905357
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 11, 2016
- Primary completion
- Jun 29, 2027
- Completion
- Jun 29, 2027
- Last update posted
- Mar 18, 2026
2016 – 2027
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama-Birmingham | Birmingham | Alabama | 35294 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| UC San Diego Medical Center | San Diego | California | 92103 | — |
| Stanford University | Stanford | California | 94305 | — |
| University of Florida Medical Center | Gainesville | Florida | 32603 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Johns Hopkins Medical Center | Baltimore | Maryland | 21287 | — |
| Dartmouth-Hitchcock | Lebanon | New Hampshire | 03766 | — |
| NYU Winthrop | Mineola | New York | 11501 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| Columbia University Medical Center/NYPH | New York | New York | 10032 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | 18015 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Seton Heart (Ascension) Univeristy of Austin, Texas | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02905357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02905357 live on ClinicalTrials.gov.